Prenatal exposure to per- and polyfluoroalkyl substances, fetoplacental hemodynamics, and fetal growth

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Knox, Bethany
  • dc.contributor.author Güil Oumrait, Núria
  • dc.contributor.author Basagaña Flores, Xavier
  • dc.contributor.author Cserbik, Dora
  • dc.contributor.author Dadvand, Payam
  • dc.contributor.author Foraster Pulido, Maria, 1984-
  • dc.contributor.author Galmes, Toni
  • dc.contributor.author Gascon Merlos, Mireia, 1984-
  • dc.contributor.author Gómez-Roig, María Dolores
  • dc.contributor.author Gómez Herrera, Laura C.
  • dc.contributor.author Haug, Line Småstuen
  • dc.contributor.author Llurba, Elisa
  • dc.contributor.author Márquez, Sandra
  • dc.contributor.author Rivas, Ioar
  • dc.contributor.author Sunyer Deu, Jordi
  • dc.contributor.author Thomsen, Cathrine
  • dc.contributor.author Zanini, Maria Julia
  • dc.contributor.author Bustamante Pineda, Mariona
  • dc.contributor.author Vrijheid, Martine
  • dc.date.accessioned 2024-11-27T07:02:36Z
  • dc.date.available 2024-11-27T07:02:36Z
  • dc.date.issued 2024
  • dc.description.abstract Introduction: The impact of legacy per- and polyfluoroalkyl substances (PFAS) on fetal growth has been well studied, but assessments of next-generation PFAS and PFAS mixtures are sparse and the potential role of fetoplacental hemodynamics has not been studied. We aimed to evaluate associations between prenatal PFAS exposure and fetal growth and fetoplacental hemodynamics. Methods: We included 747 pregnant women from the BiSC birth cohort (Barcelona, Spain (2018-2021)). Twenty-three PFAS were measured at 32 weeks of pregnancy in maternal plasma, of which 13 were present above detectable levels. Fetal growth was measured by ultrasound, as estimated fetal weight at 32 and 37 weeks of gestation, and weight at birth. Doppler ultrasound measurements for uterine (UtA), umbilical (UmA), and middle cerebral artery (MCA) pulsatility indices (PI), as well as the cerebroplacental ratio (CPR - ratio MCA to UmA), were obtained at 32 weeks to assess fetoplacental hemodynamics. We applied linear mixed effects models to assess the association between singular PFAS and longitudinal fetal growth and PI, and Bayesian Weighted Quantile Sum models to evaluate associations between the PFAS mixture and the aforementioned outcomes, controlled for the relevant covariates. Results: Single PFAS and the mixture tended to be associated with reduced fetal growth and CPR PI, but few associations reached statistical significance. Legacy PFAS PFOS, PFHpA, and PFDoDa were associated with statistically significant decreases in fetal weight z-score of 0.13 (95%CI (-0.22, -0.04), 0.06 (-0.10, 0.01), and 0.05 (-0.10, 0.00), respectively, per doubling of concentration. The PFAS mixture was associated with a non-statistically significant 0.09 decrease in birth weight z-score (95%CI -0.22, 0.04) per quartile increase. Conclusion: This study suggests that legacy PFAS may be associated with reduced fetal growth, but associations for next generation PFAS and for the PFAS mixture were less conclusive. Associations between PFAS and fetoplacental hemodynamics warrant further investigation.
  • dc.description.sponsorship This project was supported by the European Union's Horizon 2020 research and innovation programme under grant agreement no. 874,583 [ATHLETE]. The BiSC cohort was supported by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (785994 – AirNB project) and Health Effects Institute (4959-RFA17-1/18-1 – FRONTIER project) an organization jointly funded by the United States Environmental Protection Agency (EPA) (Assistance Award No. R-82811201) and certain motor vehicle and engine manufacturers. The contents of this article do not necessarily reflect the views of HEI, or its sponsors, nor do they necessarily reflect the views and policies of the EPA or motor vehicle and engine manufacturers. A full list of the funding sources that supported specific parts of the project can be found at https://projectebisc.org/en/funding-sources. Mireia Gascon holds a Miguel Servet fellowship (Grant CP19/00183) funded by Acción Estratégica de Salud - Instituto de Salud Carlos III, co-funded by European Social Fund “Investing in your future”. The publication is part of the fellowship RYC2021-032781-I awarded to Ioar Rivas, funded by the MCIN/AEI/10.13039/501100011033 and the European Union «NextGenerationEU»/PRTR. Nuria Güil-Oumrait is supported by the Secretaria d’Universitats i Recerca de la Generalitat de Catalunya (AGAUR), and Fons Social Europeu (FSE). We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. We thank all the participants and their families for their generous collaboration. A full list of BiSC researchers can be found at https://projectebisc.org/en/team/.
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Knox B, Güil-Oumrait N, Basagaña X, Cserbik D, Dadvand P, Foraster M, et al. Prenatal exposure to per- and polyfluoroalkyl substances, fetoplacental hemodynamics, and fetal growth. Environ Int. 2024 Nov;193:109090. DOI: 10.1016/j.envint.2024.109090
  • dc.identifier.doi http://dx.doi.org/10.1016/j.envint.2024.109090
  • dc.identifier.issn 0160-4120
  • dc.identifier.uri http://hdl.handle.net/10230/68835
  • dc.language.iso eng
  • dc.publisher Elsevier
  • dc.relation.ispartof Environ Int. 2024 Nov;193:109090
  • dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/874583
  • dc.relation.projectID info:eu-repo/grantAgreement/EC/H2020/785994
  • dc.rights © 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
  • dc.subject.keyword Fetal growth
  • dc.subject.keyword Mixtures
  • dc.subject.keyword PFAS
  • dc.subject.keyword Placenta
  • dc.title Prenatal exposure to per- and polyfluoroalkyl substances, fetoplacental hemodynamics, and fetal growth
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/publishedVersion